Ribavirin Can Be Mutagenic for ArenavirusesMORENO, Hector; GALLEGO, Isabel; SEVILLA, Noemi et al.Journal of virology. 2011, Vol 85, Num 14, pp 7246-7255, issn 0022-538X, 10 p.Article

A new tool to study ribavirin-induced haemolysisBROCHOT, Etienne; FRANCOIS, Catherine; CASTELAIN, Sandrine et al.Antiviral therapy (London). 2012, Vol 17, Num 7, pp 1311-1317, issn 1359-6535, 7 p.Article

Application of inorganic oxidants to the spectrophotometric determination of ribavirin in bulk and capsulesDARWISH, Ibrahim A; KHEDR, Alaa S; ASKAL, Hassan F et al.Journal of AOAC International. 2006, Vol 89, Num 2, pp 341-351, issn 1060-3271, 11 p.Article

Role of epoetin alfa in maintaining ribavirin doseAFDHAL, Nezam H.Gastroenterology clinics of North America. 2004, Vol 33, Num 1S, pp xviii-xix, issn 0889-8553, 12 p., SUPArticle

Spectrophotometric determination of acyclovir and ribavirin in their dosage formsMOHIE KHALED SHARAF EL-DIN; AMINA MOHAMMED EL-BRASHY; ZEINAB AWAD SHERIBAH et al.Journal of AOAC International. 2006, Vol 89, Num 3, pp 631-641, issn 1060-3271, 11 p.Article

Immunopharmacology of CpG oligodeoxynucleotides and ribavirinVOLLMER, Jörg; RANKIN, Robert; HARTMANN, Hanna et al.Antimicrobial agents and chemotherapy. 2004, Vol 48, Num 6, pp 2314-2317, issn 0066-4804, 4 p.Article

Ribavirin Enhances Interferon-Stimulated Gene Transcription by Activation of the Interferon-Stimulated Response ElementQIUWEI PAN; TILANUS, Hugo W; JANSSEN, Harry L. A et al.Hepatology (Baltimore, Md.). 2011, Vol 53, Num 4, pp 1400-1401, issn 0270-9139, 2 p.Article

Reduced Ribavirin Antiviral Efficacy via Nucleoside Transporter-Mediated Drug ResistanceIBARRA, Kristie D; PFEIFFER, Julie K.Journal of virology. 2009, Vol 83, Num 9, pp 4538-4547, issn 0022-538X, 10 p.Article

Discontinuation of pegylated interferon plus ribavirin in patients who are not responding to therapy : patients' views of early cessation of therapyD'SOUZA, R; MAIN, J; CROSSEY, M et al.Alimentary pharmacology & therapeutics. 2005, Vol 21, Num 1, pp 43-47, issn 0269-2813, 5 p.Article

La ribavirine = RibavirineDUCLOS-VALLEE, Jean-Charles; SAMUEL, Didier.MTP. Médecine thérapeutique pédiatrie. 2001, Vol 4, Num 1, pp 53-57, issn 1286-5494Article

Infections During Peginterferon/Ribavirin Therapy Are Associated With the Magnitude of Decline in Absolute Lymphocyte Count: Results of the IDEAL StudyMELIA, Michael T; BRÄU, Norbert; SCHIFF, Eugene et al.Clinical infectious diseases. 2014, Vol 58, Num 7, pp 960-969, issn 1058-4838, 10 p.Article

Unraveling the genetic predisposition of ribavirin-induced anaemiaASSELAH, Tarik; PASMANT, Eric; LYOUMI, Said et al.Journal of hepatology. 2010, Vol 53, Num 5, pp 971-973, issn 0168-8278, 3 p.Article

Macromolecular Prodrugs of Ribavirin: Concerted Efforts of the Carrier and the DrugSMITH, Anton A. A; WOHL, Benjamin M; KRYGER, Mille B. L et al.Advanced healthcare materials (Print). 2014, Vol 3, Num 9, pp 1404-1407, issn 2192-2640, 4 p.Article

Safety issues related to the administration of ribavirin : An update on respiratory syncytial virusKRILOV, Leonard R.The Pediatric infectious disease journal. 2002, Vol 21, Num 5, pp 479-481, issn 0891-3668Article

The predominant mechanism by which ribavirin exerts its antiviral activity in vitro against flaviviruses and paramyxoviruses is mediated by inhibition of IMP dehydrogenaseLEYSSEN, Pieter; BALZARINI, Jan; DE CLERCQ, Erik et al.Journal of virology. 2005, Vol 79, Num 3, pp 1943-1947, issn 0022-538X, 5 p.Article

Treatment of HCV with ABT-450/r- Ombitasvir and Dasabuvir with RibavirinFELD, Jordan J; KOWDLEY, Kris V; DASILVA-TILLMANN, Barbara et al.The New England journal of medicine. 2014, Vol 370, Num 17, pp 1594-1603, issn 0028-4793, 10 p.Article

Pegylated interferon plus ribavirin is suboptimal in IL28B CC carriers without rapid responseNEUKAM, Karin; BARREIRO, Pablo; RIVERO-JUAREZ, Antonio et al.The Journal of infection. 2013, Vol 67, Num 1, pp 59-64, issn 0163-4453, 6 p.Article

Pharmacokinetics, safety, and tolerability of ribavirin in hemodialysis-dependent patientsGUPTA, Samir K; KANTESARIA, Bhavna; GLUE, Paul et al.European journal of clinical pharmacology. 2012, Vol 68, Num 4, pp 415-418, issn 0031-6970, 4 p.Article

dRTP and dPTP a complementary nucleotide couple for the Sequence Saturation Mutagenesis (SeSaM) methodRUFF, Anna Joëlle; MARIENHAGEN, Jan; VERMA, Rajni et al.Journal of molecular catalysis. B, Enzymatic. 2012, Vol 84, pp 40-47, issn 1381-1177, 8 p.Conference Paper

Parainfluenza type 3 infection post stem cell transplant : high prevalence but low mortalityDIGNAN, F; ALVARES, C; RILEY, U et al.The Journal of hospital infection. 2006, Vol 63, Num 4, pp 452-458, issn 0195-6701, 7 p.Article

Developmental toxicity of ribavirin/IFα combination therapy: Is the label more dangerous than the drugs?POLIFKA, Janine E; FRIEDMAN, J. M.Birth defects research. Clinical and molecular teratology. 2003, Vol 67, Num 1, pp 8-12, issn 1542-0752, 5 p.Article

Ribavirin uptake by human erythrocytes and the involvement of nitrobenzylthioinosine-sensitive (es)-nucleoside transportersJARVIS, S. M; THORN, J. A; GLUE, P et al.British journal of pharmacology. 1998, Vol 123, Num 8, pp 1587-1592, issn 0007-1188Article

Application of sodium metaperiodate for the determination of ribavirin in pharmaceutical formulationsSASTRY, C. S. P; NAIDU, P. Y; LAKSHMI, C. S. R et al.Talanta (Oxford). 1998, Vol 47, Num 1, pp 85-93, issn 0039-9140Article

Influence of ITPA Polymorphisms on Decreases of Hemoglobin During Treatment with Pegylated Interferon, Ribavirin, and TelaprevirSUZUKI, Fumitaka; SUZUKI, Yoshiyuki; IKEDA, Kenji et al.Hepatology (Baltimore, Md.). 2011, Vol 53, Num 2, pp 415-421, issn 0270-9139, 7 p.Article

Effect of Ribavirin on the Mutation Rate and Spectrum of Hepatitis C Virus In VivoCUEVAS, José M; GONZALEZ-CANDELAS, Fernando; MOYA, Andrés et al.Journal of virology. 2009, Vol 83, Num 11, pp 5760-5764, issn 0022-538X, 5 p.Article